202 related articles for article (PubMed ID: 37561585)
1. Mast cell activation in lungs during SARS-CoV-2 infection associated with lung pathology and severe COVID-19.
Tan JY; Anderson DE; Rathore AP; O'Neill A; Mantri CK; Saron WA; Lee CQ; Cui CW; Kang AE; Foo R; Kalimuddin S; Low JG; Ho L; Tambyah P; Burke TW; Woods CW; Chan KR; Karhausen J; St John AL
J Clin Invest; 2023 Oct; 133(19):. PubMed ID: 37561585
[TBL] [Abstract][Full Text] [Related]
2. Signatures of mast cell activation are associated with severe COVID-19.
Tan J; Anderson DE; Rathore APS; O'Neill A; Mantri CK; Saron WAA; Lee C; Cui CW; Kang AEZ; Foo R; Kalimuddin S; Low JG; Ho L; Tambyah P; Burke TW; Woods CW; Chan KR; Karhausen J; John ALS
medRxiv; 2021 Jun; ():. PubMed ID: 34100020
[TBL] [Abstract][Full Text] [Related]
3. Mast cell degranulation-triggered by SARS-CoV-2 induces tracheal-bronchial epithelial inflammation and injury.
Cao JB; Zhu ST; Huang XS; Wang XY; Wu ML; Li X; Liu FL; Chen L; Zheng YT; Wang JH
Virol Sin; 2024 Apr; 39(2):309-318. PubMed ID: 38458399
[TBL] [Abstract][Full Text] [Related]
4. Severity of SARS-CoV-2 infection is associated with high numbers of alveolar mast cells and their degranulation.
Krysko O; Bourne JH; Kondakova E; Galova EA; Whitworth K; Newby ML; Bachert C; Hill H; Crispin M; Stamataki Z; Cunningham AF; Pugh M; Khan AO; Rayes J; Vedunova M; Krysko DV; Brill A
Front Immunol; 2022; 13():968981. PubMed ID: 36225927
[TBL] [Abstract][Full Text] [Related]
5. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
6. Involvement of Mast Cells in the Pathology of COVID-19: Clinical and Laboratory Parallels.
Budnevsky AV; Avdeev SN; Kosanovic D; Ovsyannikov ES; Savushkina IA; Alekseeva NG; Feigelman SN; Shishkina VV; Filin AA; Esaulenko DI; Perveeva IM
Cells; 2024 Apr; 13(8):. PubMed ID: 38667325
[TBL] [Abstract][Full Text] [Related]
7. Role of mast cells in the pathogenesis of severe lung damage in COVID-19 patients.
Budnevsky AV; Avdeev SN; Kosanovic D; Shishkina VV; Filin AA; Esaulenko DI; Ovsyannikov ES; Samoylenko TV; Redkin AN; Suvorova OA; Perveeva IM
Respir Res; 2022 Dec; 23(1):371. PubMed ID: 36544127
[TBL] [Abstract][Full Text] [Related]
8. Endothelial cell infection and dysfunction, immune activation in severe COVID-19.
Qin Z; Liu F; Blair R; Wang C; Yang H; Mudd J; Currey JM; Iwanaga N; He J; Mi R; Han K; Midkiff CC; Alam MA; Aktas BH; Heide RSV; Veazey R; Piedimonte G; Maness NJ; Ergün S; Mauvais-Jarvis F; Rappaport J; Kolls JK; Qin X
Theranostics; 2021; 11(16):8076-8091. PubMed ID: 34335981
[No Abstract] [Full Text] [Related]
9. SARS-CoV-2-triggered mast cell rapid degranulation induces alveolar epithelial inflammation and lung injury.
Wu ML; Liu FL; Sun J; Li X; He XY; Zheng HY; Zhou YH; Yan Q; Chen L; Yu GY; Chang J; Jin X; Zhao J; Chen XW; Zheng YT; Wang JH
Signal Transduct Target Ther; 2021 Dec; 6(1):428. PubMed ID: 34921131
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 and Lung Mast Cells: The Kallikrein-Kinin Activation Pathway.
Nagashima S; Dutra AA; Arantes MP; Zeni RC; Klein CK; de Oliveira FC; Piper GW; Brenny ID; Pereira MRC; Stocco RB; Martins APC; de Castro EM; Vaz de Paula CB; Amaral ANM; Machado-Souza C; Baena CP; Noronha L
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163636
[TBL] [Abstract][Full Text] [Related]
11. Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody.
Gebremeskel S; Schanin J; Coyle KM; Butuci M; Luu T; Brock EC; Xu A; Wong A; Leung J; Korver W; Morin RD; Schleimer RP; Bochner BS; Youngblood BA
Front Immunol; 2021; 12():650331. PubMed ID: 33777047
[TBL] [Abstract][Full Text] [Related]
12. Mast cell activation triggered by SARS-CoV-2 causes inflammation in brain microvascular endothelial cells and microglia.
Wu ML; Xie C; Li X; Sun J; Zhao J; Wang JH
Front Cell Infect Microbiol; 2024; 14():1358873. PubMed ID: 38638822
[TBL] [Abstract][Full Text] [Related]
13. Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice.
Dubuc I; Prunier J; Lacasse É; Gravel A; Puhm F; Allaeys I; Archambault AS; Gudimard L; Villano R; Droit A; Flamand N; Boilard É; Flamand L
Front Immunol; 2022; 13():893792. PubMed ID: 35812400
[TBL] [Abstract][Full Text] [Related]
14. Severe COVID-19 is marked by dysregulated serum levels of carboxypeptidase A3 and serotonin.
Soria-Castro R; Meneses-Preza YG; Rodríguez-López GM; Romero-Ramírez S; Sosa-Hernández VA; Cervantes-Díaz R; Pérez-Fragoso A; Torres-Ruíz JJ; Gómez-Martín D; Campillo-Navarro M; Álvarez-Jiménez VD; Pérez-Tapia SM; Chávez-Blanco AD; Estrada-Parra S; Maravillas-Montero JL; Chacón-Salinas R
J Leukoc Biol; 2021 Sep; 110(3):425-431. PubMed ID: 34057753
[TBL] [Abstract][Full Text] [Related]
15. Mast Cell's Role in Cytokine Release Syndrome and Related Manifestations of COVID-19 Disease.
Özdemir Ö; Göksu Erol AY; Dikici Ü
Curr Pharm Des; 2022; 28(40):3261-3268. PubMed ID: 36305137
[TBL] [Abstract][Full Text] [Related]
16. Mast Cells in Alveolar Septa of COVID-19 Patients: A Pathogenic Pathway That May Link Interstitial Edema to Immunothrombosis.
Motta Junior JDS; Miggiolaro AFRDS; Nagashima S; de Paula CBV; Baena CP; Scharfstein J; de Noronha L
Front Immunol; 2020; 11():574862. PubMed ID: 33042157
[TBL] [Abstract][Full Text] [Related]
17. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome.
Afrin LB; Weinstock LB; Molderings GJ
Int J Infect Dis; 2020 Nov; 100():327-332. PubMed ID: 32920235
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Inhibits NRF2-Mediated Antioxidant Responses in Airway Epithelial Cells and in the Lung of a Murine Model of Infection.
Qu Y; Haas de Mello A; Morris DR; Jones-Hall YL; Ivanciuc T; Sattler RA; Paessler S; Menachery VD; Garofalo RP; Casola A
Microbiol Spectr; 2023 Jun; 11(3):e0037823. PubMed ID: 37022178
[TBL] [Abstract][Full Text] [Related]
19. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
20. Combinational benefit of antihistamines and remdesivir for reducing SARS-CoV-2 replication and alleviating inflammation-induced lung injury in mice.
Wu ML; Liu FL; Sun J; Li X; Qin JR; Yan QH; Jin X; Chen XW; Zheng YT; Zhao JC; Wang JH
Zool Res; 2022 May; 43(3):457-468. PubMed ID: 35503561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
